In patients with lung cancer, cold atmospheric plasma (CAP) enhances the interaction between HOXB9 and the acetyltransferase P300/CBP-associated factor (PCAF), thereby increasing the level of K27 acetylation on HOXB9. This evidence concerns the gene HOXB9 and lung cancer.